Ken Griffin Nautilus Biotechnology, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 220,220 shares of NAUT stock, worth $266,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220,220
Previous 1,900
11490.53%
Holding current value
$266,466
Previous $5,000
7280.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $151M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...